AstraZeneca's China plant wins ISPE award; TPG completes buyout of Pharmatech, becomes Adare;

> AstraZeneca's ($AZN) plant in Taizhou, China won the ISPE award in project execution for being completed in 20 months and 18% under budget. Release

> A new report says the global active pharmaceutical ingredient market will hit $185.9 billion by 2020, with a compounded average growth rate of 6.5% during the forecast period from 2014 to 2020. Release

> TPG has completed its acquisition of Aptalis Pharmaceutical Technologies, known as Pharmatech, from Actavis ($ACT) and has renamed itself Adare Pharmaceuticals. Release

> Greenwich, CT-based Aptuit has increased its API manufacturing capacity at facilities in England and Italy for development work and clinical trials. Release

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.